The latest price target for Axogen (NASDAQ:AXGN) was reported by Canaccord Genuity on December 5, 2025. The analyst firm set a price target for $37.00 expecting AXGN to rise to within 12 months (a possible 23.75% upside). 17 analyst firms have reported ratings in the last year.

The latest analyst rating for Axogen (NASDAQ:AXGN) was provided by Canaccord Genuity, and Axogen maintained their buy rating.

There is no last upgrade for Axogen

There is no last downgrade for Axogen.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axogen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axogen was filed on December 5, 2025 so you should expect the next rating to be made available sometime around December 5, 2026.

While ratings are subjective and will change, the latest Axogen (AXGN) rating was a maintained with a price target of $27.00 to $37.00. The current price Axogen (AXGN) is trading at is $29.90, which is within the analyst’s predicted range.